These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 21732548

  • 41. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M, Szporn AH, Zhang D, Wasserman P, Gan L, Miller L, Burstein DE.
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [Abstract] [Full Text] [Related]

  • 42. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 43. Diagnostic usefulness of MUC1 and MUC4 for distinguishing between metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cell blocks.
    Cho JS, Kim GE, Lee JS, Lee JH, Nam JH, Choi C.
    Acta Cytol; 2013 Jul; 57(4):377-83. PubMed ID: 23860190
    [Abstract] [Full Text] [Related]

  • 44. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura.
    Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG.
    Mod Pathol; 2000 Feb; 13(2):107-12. PubMed ID: 10697265
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The diagnostic value of thrombomodulin immunolocalization in serous effusions.
    Ascoli V, Scalzo CC, Taccogna S, Nardi F.
    Arch Pathol Lab Med; 1995 Dec; 119(12):1136-40. PubMed ID: 7503662
    [Abstract] [Full Text] [Related]

  • 47. The clinical utility of the Das-1 monoclonal antibody in identifying adenocarcinoma of the colon metastatic to the liver in fine-needle aspiration tissue.
    Zimmerman RL, Das KM, Burke MA, Young NA, Solomides CC, Bibbo M.
    Cancer; 2002 Dec 25; 96(6):370-3. PubMed ID: 12478685
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.
    O'Hara CJ, Corson JM, Pinkus GS, Stahel RA.
    Am J Pathol; 1990 Feb 25; 136(2):421-8. PubMed ID: 2305835
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
    Jo VY, Cibas ES, Pinkus GS.
    Cancer Cytopathol; 2014 Apr 25; 122(4):299-306. PubMed ID: 24421209
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.
    Ordóñez NG.
    Hum Pathol; 1998 Feb 25; 29(2):166-9. PubMed ID: 9490276
    [Abstract] [Full Text] [Related]

  • 56. OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.
    Edwards C, Oates J.
    J Clin Pathol; 1995 Jul 25; 48(7):626-30. PubMed ID: 7560168
    [Abstract] [Full Text] [Related]

  • 57. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
    Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T.
    Hum Pathol; 2010 May 25; 41(5):745-50. PubMed ID: 20060157
    [Abstract] [Full Text] [Related]

  • 58. Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura.
    González-Lois C, Ballestín C, Sotelo MT, López-Ríos F, García-Prats MD, Villena V.
    Histopathology; 2001 Jun 25; 38(6):528-34. PubMed ID: 11422496
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The application of immunocytochemistry to direct smears in the diagnosis of effusions.
    Knoepp SM, Placido J, Fields KL, Thomas D, Roh MH.
    Diagn Cytopathol; 2013 May 25; 41(5):425-30. PubMed ID: 22549950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.